Midi Utama Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Midi Utama Indonesia Tbk. trades at Rp282 (market cap 9.5T, 1.62M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Midi Utama Indonesia Tbk. is far larger — about 56.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Midi Utama Indonesia Tbk. is more actively traded (1.62M versus 96.7K). Which is the better fit depends on your goals.
| MIDI | OBAT | |
|---|---|---|
Market Cap | 9.5T | 167.37B |
Volume | 1.62M | 96.7K |
Lot | 16.19K | 967 |
Turnover | 454.66M | 23.82M |
Average Price | 280.76 | 246.34 |
Value | 454.66M | 23.82M |
Indicative Equilibrium Price | 282 | 248 |
Indicative Equilibrium Volume | 803 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Midi Utama Indonesia (the company) was established under its original name of PT Midimart Utama base on notarial deed No.37 of Mr Frans Elsius, S.H, dated on 28 Jun, 2007. The Company’s articles of association has been amended several times, most recently by notarial deed No. 2 of Kamelina, S.H., dated Mar 3, 2010, concerning among others, increase in capital paid up and public offering.
Read more on MIDI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →